lu 135252 has been researched along with Ischemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bahde, R; Gupta, S; Kapoor, S; Spiegel, HU; Viswanathan, P | 1 |
| Birck, R; Braun, C; Kirchengast, M; Knoll, T; Münter, K; Rohmeiss, P; van der Woude, FJ | 1 |
| Birck, R; Braun, C; Bross, S; Juenemann, KP; Kirchengast, M; Knoll, T; Michel, MS; Rohmeiss, P; Schult, S | 1 |
3 other study(ies) available for lu 135252 and Ischemia
| Article | Year |
|---|---|
Endothelin-1 receptor A blocker darusentan decreases hepatic changes and improves liver repopulation after cell transplantation in rats.
Topics: Animals; Cell Transplantation; Dipeptidyl Peptidase 4; Endothelin A Receptor Antagonists; Hepatectomy; Hepatic Stellate Cells; Hepatocytes; Ischemia; Kupffer Cells; Liver; Liver Circulation; Liver Regeneration; Neutrophils; Phenylpropionates; Pyrimidines; Rats; Rats, Inbred F344; Rats, Mutant Strains; Transcriptome; Vasodilation | 2014 |
Improvement of postischemic acute renal failure with the novel orally active endothelin-A receptor antagonist LU 135252 in the rat.
Topics: Acute Kidney Injury; Animals; Endothelin Receptor Antagonists; Hemodynamics; Ischemia; Kidney Function Tests; Laser-Doppler Flowmetry; Male; Microcirculation; Phenylpropionates; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Renal Circulation | 1998 |
Therapeutic administration of an endothelin-A receptor antagonist after acute ischemic renal failure dose-dependently improves recovery of renal function.
Topics: Acute Kidney Injury; Animals; Creatinine; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Ischemia; Kidney; Male; Phenylpropionates; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Sodium | 2001 |